Literature DB >> 18936727

[Receptors for advanced glycation end products and their physiological and clinical significance].

Jadwiga Pietkiewicz1, Ewa Seweryn, Arkadiusz Bartyś, Andrzej Gamian.   

Abstract

The receptor for advanced glycation end products (RAGE) is a multiligand cell-surface protein and belongs to the immunoglobulin superfamily. RAGE is expressed by different cell types, including macrophages, lymphocytes, endothelial, neuronal, and smooth muscle cells. In addition to advanced glycation end products (AGEs), RAGE binds amphoterin, S100/calgranulin, amyloid, transthyretin, and a leukocyte integrin, Mac-1. Engagement of RAGE in intracellular signaling leads to the activation of the proinflammatory transcription factor NF-kappaB to sustained cellular dysfunction and tissue destruction. In this study a pivotal role of RAGE in the progression of various diseases, i.e. diabetes, inflammation, neurodegeneration, tumors, vascular injury, atherosclerosis, and septic shock, is presented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936727

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  6 in total

1.  Glycation of the muscle-specific enolase by reactive carbonyls: effect of temperature and the protection role of carnosine, pyridoxamine and phosphatidylserine.

Authors:  Jadwiga Pietkiewicz; Agnieszka Bronowicka-Szydełko; Katarzyna Dzierzba; Regina Danielewicz; Andrzej Gamian
Journal:  Protein J       Date:  2011-03       Impact factor: 2.371

Review 2.  The complement system in age-related macular degeneration.

Authors:  Angela Armento; Marius Ueffing; Simon J Clark
Journal:  Cell Mol Life Sci       Date:  2021-03-09       Impact factor: 9.261

3.  Proteins in human body fluids contain in vivo antigen analog of the melibiose-derived glycation product: MAGE.

Authors:  Kinga Gostomska-Pampuch; Andrzej Gamian; Karol Rawicz-Pruszyński; Katarzyna Gęca; Joanna Tkaczuk-Włach; Ilona Jonik; Kinga Ożga; Magdalena Staniszewska
Journal:  Sci Rep       Date:  2022-05-07       Impact factor: 4.996

Review 4.  Accumulation of Advanced Glycation End-Products in the Body and Dietary Habits.

Authors:  Agnieszka Zawada; Alicja Machowiak; Anna Maria Rychter; Alicja Ewa Ratajczak; Aleksandra Szymczak-Tomczak; Agnieszka Dobrowolska; Iwona Krela-Kaźmierczak
Journal:  Nutrients       Date:  2022-09-25       Impact factor: 6.706

5.  The Genotoxic and Pro-Apoptotic Activities of Advanced Glycation End-Products (MAGE) Measured with Micronuclei Assay Are Inhibited by Their Low Molecular Mass Counterparts.

Authors:  Monika Czech; Maria Konopacka; Jacek Rogoliński; Zbigniew Maniakowski; Magdalena Staniszewska; Łukasz Łaczmański; Danuta Witkowska; Andrzej Gamian
Journal:  Genes (Basel)       Date:  2021-05-13       Impact factor: 4.096

Review 6.  The Long Pentraxin PTX3 as a New Biomarker and Pharmacological Target in Age-Related Macular Degeneration and Diabetic Retinopathy.

Authors:  Matteo Stravalaci; Mariantonia Ferrara; Varun Pathak; Francesca Davi; Barbara Bottazzi; Alberto Mantovani; Reinhold J Medina; Mario R Romano; Antonio Inforzato
Journal:  Front Pharmacol       Date:  2022-01-07       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.